Building Intelligent Lifescience Solutions SRL
Building Intelligent Lifescience Solutions reported revenue of €20.8m for the 2025 financial year (annual accounts filed with the NBB on 18 Jun 2026).
The score of Building Intelligent Lifescience Solutions shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +165 % Total assets +379 %
Accounts of the company itself (not consolidated).
The full file covers 6 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Building Intelligent Lifescience Solutions's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 18 Jun 2026
- Year ended 31 Dec 2024filed on 24 Jun 2025
- Year ended 31 Dec 2023filed on 27 Jun 2024
- Year ended 31 Dec 2022filed on 28 Sep 2023
- Year ended 30 Jun 2021filed on 26 Jan 2022
Building Intelligent Lifescience Solutions's financial analysis
- Solvency20.6%sector median: 58.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Building Intelligent Lifescience Solutions
8 active director(s) in the register.
and 2 more
Building Intelligent Lifescience Solutions's shareholders and holdings →Building Intelligent Lifescience Solutions's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0713.961.471
- VAT number
- BE0713961471
- Peppol
- Registered · 0208:0713961471 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 27 Nov 2018
- Registered office
- 2845 Niel
- Latest accounts
- 2025 · filed on 18 Jun 2026
- Activity
- Business and other management consultancy activities (NACE 70200)
Building Intelligent Lifescience Solutions (SRL) has been based in Niel since 2018, active in: business and other management consultancy activities. For 2025, it reports revenue of €20.8m, a net profit of 451,256 € and equity of €2.16m. Its solvency stands at 20.6%, below the median of its sector (58.4%).
Companies similar to Building Intelligent Lifescience Solutions
Companies in the same business, of comparable size and area, outside its group.
- Quintuplex Engineering Business and other management consultancy activities Aartselaar · balance sheet €9.24m
- Gramme Storage 1 Business and other management consultancy activities Chaudfontaine · balance sheet €9.32m
- Bastimo Business and other management consultancy activities Sint-Niklaas · balance sheet €14.7m
- Trenmor Belgium Business and other management consultancy activities Brussels · balance sheet €8.06m
- Quercurius Business and other management consultancy activities Sint-Pieters-Leeuw · balance sheet €9.97m
- DE Groenheuvel Other manufacturing n.e.c. Laakdal · balance sheet €9.36m
- Sertius Engineering activities and related technical consultancy Brussels · balance sheet €8.70m
- Aavo Group Architectural activities Kortrijk · balance sheet €16.2m
Frequently asked questions about Building Intelligent Lifescience Solutions
What is the revenue of Building Intelligent Lifescience Solutions?
According to the 2025 annual accounts filed with the NBB, the revenue of Building Intelligent Lifescience Solutions amounts to 20,812,401 €.
What is the VAT number of Building Intelligent Lifescience Solutions?
In Belgium, the VAT number is the company number prefixed with BE: BE0713961471 for Building Intelligent Lifescience Solutions, if the company is VAT-registered. Its company number (CBE) is 0713.961.471.
Where is the registered office of Building Intelligent Lifescience Solutions?
According to the CBE register, the registered office of Building Intelligent Lifescience Solutions is in 2845 Niel.
What is the equity of Building Intelligent Lifescience Solutions?
At the close of the 2025 financial year, the equity of Building Intelligent Lifescience Solutions amounts to 2,162,821 €, a solvency of 20.6% of total assets.
Who manages Building Intelligent Lifescience Solutions?
The register lists 8 active mandates at Building Intelligent Lifescience Solutions. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Building Intelligent Lifescience Solutions
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →